RANI Rani Therapeutics Holdings, Inc.: Sotuvning operatsion marjasi

Ommaviy kompaniya Rani Therapeutics (RANI) logotipi

Og'iz orqali yetkazib berish tizimlarini joriy etish uchun sog'liqni saqlash gigantlari bilan ittifoqlarni kengaytirish uzoq muddatli o'sish uchun asos yaratadi, buni operatsion marja ko'rsatkichi tasdiqlaydi; -530.40 qiymati ushbu indikatorni aks ettiradi. Rani Therapeutics (RANI) kompaniyasining salohiyati ishlab chiqarish xarajatlari past bo'lgan, yuqori marjali RaniPill robot kapsulalariga asoslangan. Ushbu texnologiya biologik inyeksiyalarni ichakka mikroinyeksiya bilan almashtirib, ulkan dori-darmon bozoriga yo'l ochadi.

RANI - Rani Therapeutics Holdings Operatsion foyda koeffitsiyenti 04.07.2022 - 20.11.2026 oraligʻida

Rani Therapeutics Inc (RANI) kompaniyasi koʻrsatkichlari kesimi va tahlili

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Kompaniyaning fundamental baholanishi:ranitherapeutics.com, RANI
Rani Therapeutics Holdings tayyor mahsulotlari

Operatsion marja umumiy daromad ichidagi asosiy faoliyatdan olingan foyda ulushini aks ettiradi va biznesning soliqlar hamda qarz xarajatlarini hisobga olguncha daromad keltirish qobiliyatini namoyish etadi. Operatsion marja tendentsiyalarini tahlil qilish orqali investor Rani Therapeutics (RANI) kompaniyasidagi tadqiqot va ishlanmalar (R&D) xarajatlarining samaradorligini baholaydi, bunda manfiy qiymatlar inyeksiyali kapsula platformasini ishlab chiqish va strategik sherikliklarni amalga oshirish uchun naqd pul mablag'larining intensiv sarflanishini tasdiqlaydi.

Asosiy raqobatchilar

Operatsion rentabellik haleon.com|Operatsion rentabellik KVUE|Operatsion rentabellik Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operatsion foyda bo'yicha marjinallik|Operatsion marja LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operatsion rentabellik|PRGO - Operatsion rentabellik|Alvotech Corp (ALVO) - Sotuvning operatsion marjasi|LQDA: Operatsion marja|Sotuvning operatsion rentabelligi glpg.com (GLPG)|Operatsion rentabellik ANI Pharmaceuticals Inc|MNKD: Operatsion foyda normasi|Sotuvning operatsion marjasi AMPH (Amphastar)|PCRX - Sotuvning operatsion rentabelligi|Operatsion marja SPRY (ars-pharma.com)|Operatsion foyda normasi TBPH|Aquestive Therapeutics, Inc. - Operatsion marja|scpharmaceuticals.com - Operatsion foyda koeffitsiyenti|Tectonic (TECX) - Operatsion rentabellik|Sotuvning operatsion marjasi Tonix Pharmaceuticals Inc.|Operatsion rentabellik sxtchina.com|Sotuvning operatsion marjasi Eupraxia Pharmaceuticals (EPRX)|Operatsion marja BHST|EXOZ - Sotuvning operatsion rentabelligi|Oramed - Sotuvning operatsion marjasi|Entera Bio Ltd. (ENTX) - Sotuvning operatsion rentabelligi|HYFT - Operatsion rentabellik|ABVC: Operatsion rentabellik|CPIX: Operatsion marja|Quantum BioPharma Ltd. - Operatsion foyda normasi|FGEN (FibroGen Corp) - Operatsion marja|Telomir Pharma (TELO) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Synergy CHC Corp. (SNYR)|Rallybio Corp - Operatsion foyda bo'yicha sotuv rentabelligi|lexariabioscience.com - Sotuvning operatsion marjasi|Operatsion marja Pulmatrix Inc PULM|Pheton Holdings - Operatsion marja|Operatsion foyda marjasi APM|Lyra Therapeutics, Inc. (LYRA) - Operatsion rentabellik|Sotuvning operatsion rentabelligi Impact BioMedical, Inc. (IBO)|Operatsion rentabellik TNF Pharma|YCBD: Operatsion foyda normasi|Operatsion marja PRFX|CYTO - Sotuvning operatsion rentabelligi|Operatsion rentabellik Lipella LIPO|Operatsion foyda koeffitsiyenti OPTN (OptiNose, Inc.)|PIRS - Operatsion rentabellik|Procaps (PROC) - Sotuvning operatsion marjasi|PTPI: Operatsion marja|Qilian International (QLI) - Operatsion marja|Operatsion rentabellik Acelyrin, Inc.|Operatsion marja TFF Pharmaceuticals, Inc.